Skip to main content
Register
Springer Professional
SEARCH
Menu 1 2 3 4
Top

Hint

Swipe to navigate through the articles of this issue

Published in: Journal of Nanoparticle Research 7/2022

01-07-2022 | Research paper

Temozolomide associated to gold nanoparticles promoted a synergic effect and apoptosis when exposed to melanoma cells

Authors: Giulia dos Santos Pedroso-Fidelis, Maria Eduarda de Melo, Jonathann Corrêa Possato, Bruna Barros Fernandes, Ellen De Pieri, Rodrigo Cercena, Alexandre Gonçalves Dal-Bó, Paulo Emilio Feuser, Ricardo Andrez Machado-de-Ávila

Published in: Journal of Nanoparticle Research | Issue 7/2022

Login to get access
share
SHARE

Abstract

Temozolomide (TMZ) is prescribed primarily because of its known ability to cross the blood-brain barrier, being a potentially chemotherapic drug for cancer treatment. However, it has dose-limiting hemotoxicity and rapid hydrolysis, which limits its anti-tumor efficacy. On the other hand, recent studies have shown that gold nanoparticles (GNPs) with their biocompatibility and cytotoxic potential in tumor cells can be combined with chemotherapy leading to an improvement in the existing treatment. Thus, this work aimed to evaluate the cytotoxic effects of TMZ associated with GNPs (T-GNPs) on B16F10 cells. Different GNPs were successfully synthetized, and the results showed that there was an electrostatic interaction between TMZ and GNPs, not changing their physicochemical properties. TMZ associated with GNPs exposed on B16F10 cells presented a cytotoxic effect even more pronounced than free TMZ. In addition, different T-GNPs did not induced cytotoxic effect on non-tumor cells (NIH3T3 and red blood cells). A synergism between TMZ and GNPs was observed, inducing B16F10 cell death by apoptosis.
previous article Carbon dots and gold nanocluster–based hybrid microgels and their application in cells imaging
next article Catalytic activity of laser-synthesized CrOx/Al2O3 nanocatalysts with different particle sizes in isobutane dehydrogenation

To get access to this content you need the following product:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 69.000 Bücher
  • über 500 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt 90 Tage mit der neuen Mini-Lizenz testen!

inform now

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 50.000 Bücher
  • über 380 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe



 


Jetzt 90 Tage mit der neuen Mini-Lizenz testen!

inform now
Appendix
Available only for authorised users
Literature
1.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–249
2.
Domingues B, Lopes J, Soares P, Populo H (2018) Melanoma treatment in review. ImmunoTargets Ther 7:35–49 CrossRef
3.
Leonardi GC, Falzone L, Salemi R, Zanghì A, Spandidos DA, Mccubrey JA et al (2018) Cutaneous melanoma: from pathogenesis to therapy (Review). Int J Oncol 52:1071–1080
4.
Testori A, Rutkowski P, Marsden J, Bastholt L, Chiarion-Sileni V, Hauschild A et al (2009) Surgery and radiotherapy in the treatment of cutaneous melanoma. Ann Oncol 20:vi22 (Oxford University Press; [cited 2022 Jun 23]. Available from: /pmc/articles/PMC2712595/) CrossRef
5.
Strojan P (2010) Role of radiotherapy in melanoma management. Radiol Oncol 44:1 (De Gruyter; [cited 2022 Jun 23];44:1. Available from: /pmc/articles/PMC3423668/) CrossRef
6.
Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T et al (2013) Malignes melanom S3-leitlinie “Diagnostik, therapie und nachsorge des melanoms.” JDDG - J Ger Soc Dermatol 11:1–126
7.
8.
Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459–466. https://​doi.​org/​10.​1016/​S1470-2045(09)70025-7 (Elsevier Ltd) CrossRef
9.
Clemente N, Ferrara B, Gigliotti CL, Boggio E, Capucchio MT, Biasibetti E et al (2018) Solid lipid nanoparticles carrying temozolomide for melanoma treatment. Preliminary in vitro and in vivo studies. Int J Mol Sci 19:255 CrossRef
10.
Zhang JFG, Stevens MD, Bradshaw T (2012) Temozolomide: mechanisms of action, repair and resistance. Curr Mol Pharmacol 5:102–114 CrossRef
11.
Ryabaya OO, Inshakov AN, Egorova AV, Emelyanova MA, Nasedkina TV, Zasedatelev AS et al (2016) Autophagy inhibitors chloroquine and LY294002 enhance temozolomide cytotoxicity on cutaneous melanoma cell lines in vitro. Anticancer Drugs 28:307–315 CrossRef
12.
Hirose Y, Berger MS, Pieper RO (2001) p53 effects both the duration of G2/M arrest and the fate of temozolomide-treated human glioblastoma cells. Cancer Res 61:1957–1963
13.
Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S (2004) Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 11:448–457 CrossRef
14.
Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ, Rich JN et al (2009) Phase II trial of temozolomide plus O6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma. J Clin Oncol 27:1262–1267 CrossRef
15.
Bai X, Wang Y, Song Z, Feng Y, Chen Y, Zhang D et al (2020) The basic properties of gold nanoparticles and their applications in tumor diagnosis and treatment. Int J Mol Sci 21:2480 CrossRef
16.
de Pinho RA, Haupenthal DPS, Feuser PE, Thirupathi A, Silveira PCL (2022) Gold Nanoparticle-based therapy for muscle inflammation and oxidative stress. J Inflamm Res 15:3219–3234 CrossRef
17.
Li H, Jin H, Wan W, Wu C, Wei L (2018) Cancer nanomedicine: mechanisms, obstacles and strategies. Nanomedicine. 13:1639–1656 CrossRef
18.
Sztandera K, Gorzkiewicz M, Klajnert-Maculewicz B (2019) Gold nanoparticles in cancer treatment. Mol Pharm 16:1–23 CrossRef
19.
Mukherjee P, Bhattacharya R, Wang P, Wang L, Basu S, Nagy JA et al (2005) Antiangiogenic properties of gold nanoparticles. Clin Cancer Res 11:3530–3534 CrossRef
20.
21.
Chou TC (2010) Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res 70(2):440–446 CrossRef
22.
Orza A, Soriţǎu O, Tomuleasa C, Olenic L, Florea A, Pana O et al (2013) Reversing chemoresistance of malignant glioma stem cells using gold nanoparticles. Int J Nanomedicine 8:689–702 CrossRef
23.
Feuser PE, Cordeiro AP, de Bem SG, Borges Corrêa MEA, Lock Silveira PC, Sayer C et al (2021) Co-encapsulation of sodium diethyldithiocarbamate (DETC) and zinc phthalocyanine (ZnPc) in liposomes promotes increases phototoxic activity against (MDA-MB 231) human breast cancer cells. Colloids Surf B: Biointerfaces 197:111434 (Elsevier) CrossRef
24.
Della Vechia IC, Steiner BT, Freitas ML, dos Santos Pedroso Fidelis G, Galvani NC, Ronchi JM et al (2020) Comparative cytotoxic effect of citrate-capped gold nanoparticles with different sizes on noncancerous and cancerous cell lines. J Nanopart Res 22:1–11 CrossRef
25.
Fan L, Wang W, Wang Z, Zhao M (2021) Gold nanoparticles enhance antibody effect through direct cancer cell cytotoxicity by differential regulation of phagocytosis. Nat Commun 12:1–13 (Springer US) CrossRef
26.
Cordeiro AP, Feuser PE, Figueiredo PG, da Cunha ES, Martinez GR, Machado-de-Ávila RA et al (2021) In vitro synergic activity of diethyldithiocarbamate and 4-nitrochalcone loaded in beeswax nanoparticles against melanoma (B16F10) cells. Mater Sci Eng C 120:111651 CrossRef
27.
28.
Mateo D, Morales P, Ávalos A, Haza AI (2015) Comparative cytotoxicity evaluation of different size gold nanoparticles in human dermal fibroblasts. J Exp Nanosci 10:1401–1417 CrossRef
29.
Mohan JC, Praveen G, Chennazhi KP, Jayakumar R, Nair SV (2013) Functionalised gold nanoparticles for selective induction of in vitro apoptosis among human cancer cell lines. J Exp Nanosci 8:32–45 CrossRef
30.
31.
32.
Afzalipour R, Khoei S, Khoee S, Shirvalilou S, Jamali Raoufi N, Motevalian M et al (2019) Dual-targeting temozolomide loaded in folate-conjugated magnetic triblock copolymer nanoparticles to improve the therapeutic efficiency of rat brain gliomas. ACS Biomater Sci Eng 5:6000–6011 CrossRef
33.
Wang W, Ding X, Xu Q, Wang J, Wang L, Lou X (2016) Zeta-potential data reliability of gold nanoparticle biomolecular conjugates and its application in sensitive quantification of surface absorbed protein. Colloids Surf B: Biointerfaces 148:541–548 (Elsevier B.V.) CrossRef
34.
Wang L, Tang S, Yu Y, Lv Y, Wang A, Yan X et al (2021) Intranasal delivery of temozolomide-conjugated gold nanoparticles functionalized with anti-EphA3 for glioblastoma targeting. Mol Pharm 18:915–927 ([cited 2022 Jun 3]. American Chemical Society. Available from: https://​pubs.​acs.​org/​doi/​full/​10.​1021/​acs.​molpharmaceut.​0c00911) CrossRef
35.
dos Santos Haupenthal DP, Zortea D, Zaccaron RP, de Bem SG, Corrêa MEAB, Mendes C et al (2020) Effects of phonophoresis with diclofenac linked gold nanoparticles in model of traumatic muscle injury. Mater Sci Eng C 110:110681 (Elsevier Ltd) CrossRef
36.
Cseh AM, Fabian Z, Quintana-Cabrera R, Szabo A, Eros K, Soriano ME et al (2019) PARP inhibitor PJ34 protects mitochondria and induces DNA-damage mediated apoptosis in combination with cisplatin or temozolomide in B16F10 melanoma cells. Front Physiol 10:1–15 CrossRef
37.
38.
39.
Rafiei S, Rezatofighi SE, Ardakani MR, Rastegarzadeh S (2016) Gold nanoparticles impair foot-and-mouth disease virus replication. IEEE Trans Nanobiosci 15:34–40 CrossRef
40.
Uggioni MLR, Feuser PE, Possato JC, de Melo ME, De Pieri E, Cercena R et al (2022) Synergic effect of paclitaxel and cisplatin associated with gold nanoparticles on HeLa cervical cells. Gold Bull 2021:1–11 (Springer; [cited 2022 Jan 26]. Available from: https://​link.​springer.​com/​article/​10.​1007/​s13404-021-00305-5)
41.
Fadera S, Chen PY, Liu HL, Lee IC (2021) Induction therapy of retinoic acid with a temozolomide-loaded gold nanoparticle-associated ultrasound effect on glioblastoma cancer stem-like colonies. ACS Appl Mater Interfaces 13:32845–32855 CrossRef
42.
Gialluca VD, de Lima VGP, Caixeta A, Castilho ML, Raniero LJ (2021) Gold nanoparticles associated with temozolomide for glioblastoma multiforme treatment. Res Soc Dev 10:e146101119406 (Research, Society and Development; [cited 2022 Jun 3]. Available from: https://​rsdjournal.​org/​index.​php/​rsd/​article/​view/​19406) CrossRef
43.
Shojaei S, Koleini N, Samiei E, Aghaei M, Cole LK, Alizadeh J et al (2020) Simvastatin increases temozolomide-induced cell death by targeting the fusion of autophagosomes and lysosomes. FEBS J 287:1005–1034 (John Wiley & Sons, Ltd; [cited 2021 Dec 3];Available from: https://​onlinelibrary.​wiley.​com/​doi/​full/​10.​1111/​febs.​15069) CrossRef
44.
45.
Fornaguera C, Calderó G, Mitjans M, Vinardell MP, Solans C, Vauthier C (2015) Interactions of PLGA nanoparticles with blood components: protein adsorption, coagulation, activation of the complement system and hemolysis studies. Nanoscale. 7:6045–6058 CrossRef
46.
Yang X, Yang M, Pang B, Vara M, Xia Y (2015) Gold nanomaterials at work in biomedicine. Chem Rev 115:10410–10488 CrossRef
47.
Vlachostergios PJ, Papandreou CN (2015) Efficacy of low dose temozolomide in combination with bortezomib in U87 glioma cells: a flow cytometric analysis. Arch Med Sci 11:307–310 CrossRef
Metadata
Title
Temozolomide associated to gold nanoparticles promoted a synergic effect and apoptosis when exposed to melanoma cells
Authors
Giulia dos Santos Pedroso-Fidelis
Maria Eduarda de Melo
Jonathann Corrêa Possato
Bruna Barros Fernandes
Ellen De Pieri
Rodrigo Cercena
Alexandre Gonçalves Dal-Bó
Paulo Emilio Feuser
Ricardo Andrez Machado-de-Ávila
Publication date
01-07-2022
Publisher
Springer Netherlands
Published in
Journal of Nanoparticle Research / Issue 7/2022
Print ISSN: 1388-0764
Electronic ISSN: 1572-896X
DOI
https://doi.org/10.1007/s11051-022-05524-1

Other articles of this Issue 7/2022

Journal of Nanoparticle Research 7/2022 Go to the issue

Review

Chalcogenide perovskites for photovoltaic applications: a review

Research paper

Catalytic activity of laser-synthesized CrOx/Al2O3 nanocatalysts with different particle sizes in isobutane dehydrogenation

Research paper

Effects of laser penetration depth and temperature on the stability of afatinib-loaded gold nanoparticles: an optical limiting study

Research paper

Synthetic 2D tellurium nanosheets with intense TE wave polarization absorption by employing the PVD method

Research paper

Facile one-pot synthesis of bimodal-sized nickel nanoparticles in a solvent-directed reaction system

Research paper

Hydrogen and humidity sensing characteristics of Nafion, Nafion/graphene, and Nafion/carbon nanotube resistivity sensors

Premium Partners

in-adhesives MKVS Hellmich GmbH Krahn Ceramics
    Image Credits